Another mechanism of PGE2-mediated immune suppression is the enhancement of Treg function, as evidenced by the finding that combination treatment comprising an EP4 plus an EP2 antagonist reduced the number of tumor-infiltrating Tregs in vivo and PGE2-mediated stabilization of Tregs in vitro [17]. The gene discussed is PTGER2; the disease is neoplasm.